Abstract

Aims:
To determine how chronic hepatitis D virus (HDV) infection affects intrahepatic hepatitis B virus (HBV) antigen expression. Methods: Ninety eight liver biopsy specimens from 68 patients seropositive for total antibody to HDV were studied by immunohistochemistry, and the amount of HBV antigens was also quantified by radioimmunoassay in 12 patients and compared with 30 patients with chronic HBV infection. Results: Forty nine of the 68 patients were positive for intrahepatic HDV antigen and only five were positive for HBV core antigen (HBcAg). HBV surface antigen (HBsAg) was present in 55 (80-9%) patients and was always cytoplasmic in distribution. Hepatic pre-S, and pre-S2 expressions paralleled that of HBsAg, and were detected in 53 (77-9%) and 54 (79-4%) patients, respectively. There was no relation between the intrahepatic expression of HDV antigen and HBsAg/pre-S1/pre-S2. Follow up biopsy specimens in 25 patients showed either static or deteriorating histology while intrahepatic HDV antigen remained the same or fell. The patients with intrahepatic expression of HBcAg had either absent or noticeably decreased expression of HBcAg in their follow up biopsy specimens (median two years). In contrast, HBsAg/pre-SI/pre-S2 were the same or increased (p < 0 0001). Quantification of intrahepatic HBsAg in patients with chronic HDV infection (0-61 pg/hepatocyte, range: 0-05-1-08, n = 12) showed no difference with patients with chronic HBV infection alone (0-64 pg/hepatocyte, range: 0-02-1-02, n = 30, p = NS). minutes. The monoclonal antibodies to pre-SI and pre-S2 were chosen according to a recent study which showed that these antibodies were the most sensitive for detecting the pre-S antigens.'2 After washing in TBS, appropriate second layer antibody conjugated to alkaline phosphatase was applied (HBsAg/pre-S, pre-S2: rabbit anti-mouse, HBcAg: swine antirabbit, dilution 1 in 30) for 30 minutes at room temperature. The alkaline phosphatase reaction was developed using napthol and Fast Red TR salt (Sigma, Dorset, England) as described. The sections were then washed, counterstained with haematoxylin, and mounted in glycerol in TBS (1:1).
The expression of HDV antigen and HBV antigens was scored independently by two ofus (JYNL, BCP) on a 0-4 + scale, corresponding to positivity in 0%, 1-5%, 5-30%, 30-60%, and > 60% of hepatocytes examined. QUANTIFICATION Patients with positive intrahepatic HDV antigen (n = 49) had a higher serum titre of HBsAg (median 1:12 800, range 1:32-51 200) compared with those negative for intrahepatic HDV antigen (median 1: 1600, range 1:4-6400, n = 19; p < 0-05).
INTRAHEPATIC EXPRESSION OF HBSAG AND PRE-S ANTIGENS
Intrahepatic HBsAg was detected in the liver biopsy specimens ofmost patients (table 3) and the distribution was nearly always diffuse cytoplasmic, with three patients showing a membraneous pattern of HBsAg on top of the predominantly cytoplasmic HBsAg. Two of these three patients were positive for intrahepatic HBcAg and seropositive for both HBeAg and HBV DNA. The median expression of HBsAg was 1+ (range 0-4+), but a strong diffuse positive reaction was seen in seven patients ( > 3 +, 10 3%), six ofwhom had histological evidence of cirrhosis. Pre-S, and pre-S2 were detected in the liver in nearly all biopsy specimens positive for HBsAg (p < 00001). Immunohistochemicalexamination in serial liver sections showed that the distribution of the pre-S antigens was the same as HBsAg with most hepatocytes expressing HBsAg also express both pre-S antigens.
There was no correlation between intrahepatic expression ofHDV antigen and HBsAg 
NSRC-
or pre-S antigens. Immunohistochemical staining in serial liver biopsy specimens showed that hepatocytes expressing HDV antigen were frequently negative or weakly positive for HBsAg and pre-S antigens.
However, occasional hepatocytes positive for HDV antigen were also strongly positive for HBsAg and pre-S antigens.
No correlation exists between serum titre of HBsAg and intrahepatic expression of HBsAg, pre-S, and pre-S2, although patients with strong diffuse intrahepatic expression ofHBsAg and pre-S antigens (n = 7) tended to have a lower titre of serum HBsAg (p = 00677). Intrahepatic expression of HBsAg or pre-S antigens had no association with either histological activity index or any of its individual factors (lobular inflammation, piece-meal necrosis, portal inflammation). Subset analysis of biopsy specimens positive (n = 75) or negative (n = 23) for intrahepatic HDV antigen also showed no correlation between intrahepatic expression of HBV surface antigens and histological activities. There was no correlation between the expression of intrahepatic HBsAg or pre-S antigens and the extent of fibrosis.
In relation to patients with chronic HBV infection alone, there was no difference in the intrahepatic expression of HBsAg and the pre-S antigens as determined by immunohistochemistry in different histological groups (according to the intemational accepted criteria listed in table 1) between patients with chronic HBV (n = 30) and chronic HDV infection (n = 68). Quantification ofthe amount ofintrahepatic HBsAg per positive hepatocyte (table  2) showed no difference between patients with chronic HBV infection (median 0-64 pg/ hepatocyte, range 0-02-1-02, n = 30) and chronic HDV infection (median 0-71, range 0-05-1-08, n = 12; p = NS).
In 25 patients (three negative for intrahepatic HDV antigen) with follow up biopsy specimens at a median of two years (range one to five years), liver histology either remained static or deteriorated while intrahepatic expression of HDV antigen remained the same or fell. In contrast, these follow up biopsy specimens showed either the same (n = 10) or increased intrahepatic HBsAg expression (figure). 
Discussion
